semaglutide logo The Ozempic has a clever but controversial secret Compounded Semaglutide (GLP-1)

Its licensed and dosed as a diabetes medication, where the aim is blood sugar control rather than weight loss

Himss risk is billing friction and high branded cost

There is no consensus about the upper reference limits for plasma homocysteine concentrations

State Supplemental Rebates: States may need to renegotiate rebate agreements, with some states potentially achieving savings of up to 15% on GLP-1 medication costs through innovative pricing models such as outcomes-based contracts

Care should be taken to monitor water retention , blood glucose , and prolactin especially during longer cycles or when stacking with other GH-related compounds

sulphur burps are not captured as a discrete adverse event but are a recognised patient complaint across the GLP-1 agonist class